The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib (O) in advanced triple negative breast cancer (aTNBC) patients (pts) with BRCA1/2 promoter methylation: GEICAM/2015-06 study (COMETA-Breast).
 
Juan De La Haba
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly O.; Novartis; Pfizer; Roche
Research Funding - Pfizer
 
Antonio Anton
Consulting or Advisory Role - Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.
Speakers' Bureau - AstraZeneca; Daiichi Sankyo Pharmaceutical; Lilly O.; Seagen
Expert Testimony - Lilly O.; Pfizer
 
Vanesa Quiroga
Consulting or Advisory Role - Roche
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - GlaxoSmithKline; Lilly O.; Roche
 
Angel Guerrero
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo Pharmaceutical; Exact Sciences; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Research Funding - Lilly O.
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Pfizer
 
Raquel Andrés
Consulting or Advisory Role - Lilly; seagen
Speakers' Bureau - daichi; Lilly; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Pierre Fabre
 
Mireia Mele
Speakers' Bureau - Daichii -Sankyo
 
Santiago Gonzalez- Santiago
Honoraria - Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Pierre Fabre
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Clovis Oncology; Pfizer
 
Jose Alejandro Perez-Fidalgo
Consulting or Advisory Role - Ability Pharma; Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche; Tesaro
Speakers' Bureau - AstraZeneca Spain; Clovis Oncology; GlaxoSmithKline; Ipsen; Novartis; Pfizer; PharmaMar; Roche; Seagen
Research Funding - AstraZeneca Spain (Inst); GlaxoSmithKline (Inst); Pharmamar (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca Spain; Novartis
 
Teresa Ramon y Cajal
No Relationships to Disclose
 
Maria Jose Escudero
No Relationships to Disclose
 
Susana Bezares
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Federico Rojo
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; GlaxoSmithKline; Menarini; Merck; MSD; Novartis; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; BMSi; GlaxoSmithKline; Menarini; Merck; MSD; Novartis; Roche
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMSi; MSD; Roche